Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.

Cohort Studies Coronary Artery Disease / epidemiology Hemorrhage / chemically induced Humans Japan / epidemiology Percutaneous Coronary Intervention / adverse effects Platelet Aggregation Inhibitors / adverse effects Registries Risk Factors Treatment Outcome
Coronary artery disease High bleeding risk Percutaneous coronary intervention

Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 04 2022
Historique:
pubmed: 17 9 2021
medline: 27 4 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

Optimal intensity is unclear for P2Y In this historical comparative study, Cohort-3 compared with Cohort-2 was associated with excess bleeding risk, which might be at least partly explained by the difference in P2Y

Sections du résumé

BACKGROUND
Optimal intensity is unclear for P2Y
CONCLUSIONS
In this historical comparative study, Cohort-3 compared with Cohort-2 was associated with excess bleeding risk, which might be at least partly explained by the difference in P2Y

Identifiants

DOI: 10.1253/circj.CJ-21-0526 PMID: 34526432
pubmed: 34526432
doi: 10.1253/circj.CJ-21-0526
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

748-759

Commentaires et corrections

Type : CommentIn

Auteurs

Masahiro Natsuaki (M)

Department of Cardiovascular Medicine, Saga University.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine.

Hiroki Shiomi (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Ko Yamamoto (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Kyohei Yamaji (K)

Department of Cardiology, Kokura Memorial Hospital.

Hirotoshi Watanabe (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Takashi Uegaito (T)

Department of Cardiology, Kishiwada City Hospital.

Mitsuo Matsuda (M)

Department of Cardiology, Kishiwada City Hospital.

Toshihiro Tamura (T)

Department of Cardiology, Tenri Hospital.

Ryoji Taniguchi (R)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center.

Moriaki Inoko (M)

Department of Cardiology, Kitano Hospital.

Hiroshi Mabuchi (H)

Department of Cardiology, Koto Memorial Hospital.

Teruki Takeda (T)

Department of Cardiology, Koto Memorial Hospital.

Takenori Domei (T)

Department of Cardiology, Kokura Memorial Hospital.

Manabu Shirotani (M)

Department of Cardiology, Kindai University Nara Hospital.

Natsuhiko Ehara (N)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.

Hiroshi Eizawa (H)

Department of Cardiovascular Medicine, Kobe City Nishi-Kobe Medical Center.

Katsuhisa Ishii (K)

Department of Cardiology, Kansai Denryoku Hospital.

Masaru Tanaka (M)

Department of Cardiology, Osaka Red Cross Hospital.

Tsukasa Inada (T)

Department of Cardiology, Osaka Red Cross Hospital.

Tomoya Onodera (T)

Department of Cardiology, Shizuoka City Shizuoka Hospital.

Ryuzo Nawada (R)

Department of Cardiology, Shizuoka City Shizuoka Hospital.

Eiji Shinoda (E)

Department of Cardiology, Hamamatsu Rosai Hospital.

Miho Yamada (M)

Department of Cardiology, Hamamatsu Rosai Hospital.

Takashi Yamamoto (T)

Department of Cardiology, Shiga University of Medical Science Hospital.

Hiroshi Sakai (H)

Department of Cardiology, Shiga University of Medical Science Hospital.

Mamoru Toyofuku (M)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Takashi Tamura (T)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Mamoru Takahashi (M)

Department of Cardiology, Shimabara Hospital.

Tomohisa Tada (T)

Department of Cardiology, Shizuoka General Hospital.

Hiroki Sakamoto (H)

Department of Cardiology, Shizuoka General Hospital.

Takeshi Tada (T)

Department of Cardiology, Kurashiki Central Hospital.

Kazuhisa Kaneda (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Shinji Miki (S)

Department of Cardiology, Mitsubishi Kyoto Hospital.

Takeshi Aoyama (T)

Division of Cardiology, Shimada Municipal Hospital.

Satoru Suwa (S)

and Department of Cardiology, Juntendo University Shizuoka Hospital.

Yukihito Sato (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center.

Kenji Ando (K)

Department of Cardiology, Kokura Memorial Hospital.

Yutaka Furukawa (Y)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.

Yoshihisa Nakagawa (Y)

Department of Cardiology, Shiga University of Medical Science Hospital.

Kazushige Kadota (K)

Department of Cardiology, Kurashiki Central Hospital.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Ischémie myocardique › Maladie coronarienne › Maladie des artères coronaires › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Hémorragie › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Régions géographiques › Iles › Japon › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Procédures endovasculaires › Intervention coronarienne percutanée › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Antiagrégants plaquettaires › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enregistrements › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Bleeding Outcomes After Percutaneous Coronary...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Bleeding Outcomes After Percutaneous Coronary...